Catalyst Wire Dossier Catalyst Wire Dossier

PMIT (Oral Immunotherapy for Peanut Allergy)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PMIT (Oral Immunotherapy for Peanut Allergy), covering 2017-05-03 to 2017-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Oral Immunotherapy for Peanut Allergy (PMIT) [Phase 2]

See pricing